Zobrazeno 1 - 10
of 2 787
pro vyhledávání: '"Hulshof M"'
Autor:
Feldman, E., Pos, F.J., Smeenk, R.J., van der Poel, H., van Leeuwen, P., de Feijter, J.M., Hulshof, M., Budiharto, T., Hermens, R., de Ligt, K.M., Walraven, I.
Publikováno v:
In ESMO Open February 2023 8(1)
Autor:
Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. Electronic address: jens@oncology.au.dk., Ccm Hulshof M; Amsterdam University Medical Centers, Department of Radiotherapy, University of Amsterdam, the Netherlands., Dahl O; Department of Oncology and Medical Physics, Haukeland University, Hospital, Bergen, Norway. Electronic address: olav@dahlpost.no., Arcangeli G; Regina Elena National Cancer Institute, Rome, Italy.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul; Vol. 196, pp. 110313. Date of Electronic Publication: 2024 Apr 24.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
van der Aa DC; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands., Gisbertz SS; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands., Anderegg MCJ; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands., Lagarde SM; Department of Surgery, Erasmus Medical Center, Rotterdam, Netherlands., Klaassen R; Department of Medical Oncology, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands., Meijer SL; Department of Pathology, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands., van Dieren S; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands., Hulshof M; Department of Radiotherapy, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands., Bergman J; Department of Gastroenterology, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands., Bennink RJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands., van Laarhoven HWM; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, Netherlands.; Department of Medical Oncology, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands., van Berge Henegouwen MI; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, Netherlands. m.i.vanbergehenegouwen@amsterdamumc.nl.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, Netherlands. m.i.vanbergehenegouwen@amsterdamumc.nl.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands. m.i.vanbergehenegouwen@amsterdamumc.nl.
Publikováno v:
Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Mar; Vol. 55 (1), pp. 270-280. Date of Electronic Publication: 2023 Jul 01.
Autor:
Vernooij, R. W. M., Cremers, R. G. H. M., Jansen, H., Somford, D. M., Kiemeney, L. A., van Andel, G., Wijsman, B. P., Busstra, M. B., van Moorselaar, R. J. A., Wijnen, E. M., Pos, F. J., Hulshof, M. C. C. M., Hamberg, P., van den Berkmortel, F., Hulsbergen-van de Kaa, C. A., van Leenders, G. J. L. H., F€utterer, J. J., van Oort, I. M., Aben, K. K. H.
Publikováno v:
Urologic Oncology: Seminars and Original Investigations, 40(7). Elsevier Inc.
Vernooij, R W M, Cremers, R G H M, Jansen, H, Somford, D M, Kiemeney, L A, van Andel, G, Wijsman, B P, Busstra, M B, van Moorselaar, R J A, Wijnen, E M, Pos, F J, Hulshof, M C C M, Hamberg, P, van den Berkmortel, F, Hulsbergen-van de Kaa, C A, van Leenders, G J L H, F€utterer, J J, van Oort, I M & Aben, K K H 2022, ' Corrigendum to “Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer : A nationwide observational study” (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022)) ', Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 7, pp. 353 . https://doi.org/10.1016/j.urolonc.2022.05.007
Urologic oncology, 40(7). Elsevier Inc.
Vernooij, R W M, Cremers, R G H M, Jansen, H, Somford, D M, Kiemeney, L A, van Andel, G, Wijsman, B P, Busstra, M B, van Moorselaar, R J A, Wijnen, E M, Pos, F J, Hulshof, M C C M, Hamberg, P, van den Berkmortel, F, Hulsbergen-van de Kaa, C A, van Leenders, G J L H, F€utterer, J J, van Oort, I M & Aben, K K H 2022, ' Corrigendum to “Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer : A nationwide observational study” (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022)) ', Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 7, pp. 353 . https://doi.org/10.1016/j.urolonc.2022.05.007
Urologic oncology, 40(7). Elsevier Inc.
The authors regret that the following statements were incorrectly mentioned in the paper. Page 4, line 333, paragraph 3.1. Descriptive statistics: “.2358.” should be 2538 Page 4, line 338-340, paragraph 3.1. Descriptive statistics: “.and were t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5db9ac6c33daac385d9187bc05ef619d
https://research.vumc.nl/en/publications/7bf2f294-6884-4306-b65e-14f0de58c5d3
https://research.vumc.nl/en/publications/7bf2f294-6884-4306-b65e-14f0de58c5d3
Publikováno v:
Azzarouali, S, Goudschaal, K, den Boer, D, Visser, J, Hulshof, M & Bel, A 2022, ' AI-based online adaptive CBCT-guided radiotherapy for bladder cancer using SIB and fiducial markers ', Radiotherapy and Oncology, vol. 170, pp. S196-S197 .
Radiotherapy and Oncology, 170, S196-S197. Elsevier Ireland Ltd
Radiotherapy and Oncology, 170, S196-S197. Elsevier Ireland Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7de3ef309d0aecc056fee56985a96002
https://research.vumc.nl/en/publications/2a300f02-f567-4cb7-b282-90f65a51e0bd
https://research.vumc.nl/en/publications/2a300f02-f567-4cb7-b282-90f65a51e0bd
Autor:
Evers, Jelle, Kerkmeijer, L.G.W., Bergh, R.C. van den, Sangen, M.J. van der, Hulshof, M., Bloemers, M., Siesling, S., Aarts, M.J., Aben, K.K.H., Struikmans, H.
Publikováno v:
Radiotherapy and oncology, 177, 134-142. Elsevier Ireland Ltd
Radiotherapy and Oncology, 177, pp. 134-142
Radiotherapy and oncology, 177, 134-142. Elsevier
Radiotherapy and Oncology, 177, 134-142
Radiotherapy and Oncology, 177, pp. 134-142
Radiotherapy and oncology, 177, 134-142. Elsevier
Radiotherapy and Oncology, 177, 134-142
Contains fulltext : 287329.pdf (Publisher’s version ) (Open Access) PURPOSE: This population-based study describes nationwide trends and variation in the use of primary radiotherapy for non-metastatic prostate cancer in The Netherlands in 2008-2019
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64e459fdbf6faba55da83f8c21d9cc7
https://pure.amc.nl/en/publications/trends-and-variation-in-the-use-of-radiotherapy-in-nonmetastatic-prostate-cancer(448d0148-ff29-455b-9c9d-2bdec730b2c4).html
https://pure.amc.nl/en/publications/trends-and-variation-in-the-use-of-radiotherapy-in-nonmetastatic-prostate-cancer(448d0148-ff29-455b-9c9d-2bdec730b2c4).html
Autor:
Ripping, T. M., Rammant, E., Witjes, J. A., Aaronson, N. K., van Hemelrijck, M., van Hoogstraten, L. M.C., Boormans, J., Goossens, C. A., van der Heijden, A. G., Hulshof, M. C.C.M., van Leenders, G. J.L.H., van Leliveld, A. M., Meijer, R. P., van Moorselaar, R. J.A., Mulder, S. F., Nooter, R. I., Noteboom, J. L., Oddens, J. R., de Reijke, T. M., van Rhijn, B. W.G., van Roermund, J. G.H., Smilde, T. J., Vanderbosch, G. W.J., Wijsman, B. P., Kiemeney, L. A., Aben, K. K.H.
Publikováno v:
BlaZIB Study Group 2022, ' Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer ', Health and Quality of Life Outcomes, vol. 20, no. 1, 171 . https://doi.org/10.1186/s12955-022-02064-z
Health and quality of life outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20, 1
Health and Quality of Life Outcomes, 20
Health and quality of life outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20, 1
Health and Quality of Life Outcomes, 20
Background Quality of Life (QoL) of bladder cancer patients has been largely neglected. This is partly due to the lack of well-validated QoL questionnaires. The aim of this study is to examine the structural validity, reliability (i.e., internal cons
Publikováno v:
In Clinical Oncology September 2014 26(9):522-532
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.